physcione has been researched along with Colorectal Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Gao, H; Han, Y; Wang, C; Xie, J; Ye, J | 1 |
| Chen, XH; Gao, H; Han, YT; Wang, CB; Ye, JL | 1 |
2 other study(ies) available for physcione and Colorectal Cancer
| Article | Year |
|---|---|
RETRACTED: Physcion induces mitochondria-driven apoptosis in colorectal cancer cells via downregulating EMMPRIN.
Topics: AMP-Activated Protein Kinases; Antineoplastic Agents; Apoptosis; Basigin; Cell Cycle; Cell Survival; Colorectal Neoplasms; Dose-Response Relationship, Drug; Down-Regulation; Emodin; HCT116 Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mitochondria; Signal Transduction | 2015 |
Physcion inhibits the metastatic potential of human colorectal cancer SW620 cells in vitro by suppressing the transcription factor SOX2.
Topics: AMP-Activated Protein Kinases; Antineoplastic Agents; Cell Line, Tumor; Colon; Colorectal Neoplasms; Down-Regulation; Emodin; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3 beta; Humans; Neoplasm Metastasis; Reactive Oxygen Species; Rectum; Signal Transduction; SOXB1 Transcription Factors | 2016 |